The main area of company’s activity is search, extraction, research and production of new DNA enzymes and their application in modern life sciences.

For more than 20 years company become the world third producer of restriction endonucleases, main producer of new enzyme type – methyl-directed DNA endonucleases. Has more than 15 patents.

Products range includes traditional restriction endonucleases, PCR reagents, methyl-directed DNA endonucleases, applied in epigenetics studies

We suplly our products worldwide: USA, EU, Japan, China, India, Australia, Malaysia, Korea, Turkey, etc.

SibEnzyme is developer of GLAD-PCR-Assay

The SYGMA.Novosibirsk multidisciplinary nanotechnology centre provides a full range of services for the development of nanotech startups.

The SYGMA.Novosibirsk nanocentre was created in 2011 by the Fund for Infrastructure and Educational Programs in partnership with RUSNANO, the Administration of the Novosibirsk Region, Technopark of Novosibirsk Akademgorodok and the Siberian Branch of the Russian Academy of Sciences. In 2013, two independent nanocentres were formed in Novosibirsk and Tomsk based on an existing design.
Twenty-one high-tech projects are being realised at the SYGMA.Novosibirsk nanocentre and 20 more are under development. The major technological platforms for startup development are:

«SYGMA.Novosibirsk is part of the network of nanocentres created by RUSNANO, which unites  the Zelenograd Nanotechnology Centre, the Dubna, SYGMA.Tomsk, TechnoSpark; (Troitsk) and T-NANO(Moscow) nanocentres, the Nanotechnology Composite Centre (Moscow), Northwest Nanotechnology Centre (Gatchina, Leningrad Region), Ulyanovsk Nanotechnology Centre, Centre for Nanotechnology and Nanomaterials in the Republic of Mordovia (Saransk) and the Republic of Tatarstan Nanotechnology Center (Kazan).

The State Research Center of Virology and Biotechnology VECTOR

Center was founded in 1974. Basic research is focused on generating new scientific knowledge in molecular biology, virology, genetic engineering, biotechnology, epidemiology and ecology. VECTOR comprises several research institutes, production units, and other departments. Moreover, the VECTOR is an associated member of several unions and associations, both in Russia and internationally. VECTOR is one of the leading world center, developing Ebola vaccine.

VECTOR is the developer of pilot colorectal cancer test